Ezetimibe

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

75 Suppliers, 30 USDMF, 10 JDMF, 15 EU WC, 61 KDMF, 17 NDC API, 49 Listed Suppliers

DEVELOPMENTS

16 Drug(s) in Development

16 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

27 Suppliers

27 Suppliers

DOSSIERs // Finished Dosage Forms

312 Dossiers, 62 FDA Orange Book, 76 Europe, 21 Canada, 21 Australia, 35 South Africa, 97 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 10MG, TABLET;ORAL - 10MG;10MG, TABLET;ORAL - 10MG;20MG, TABLET;ORAL - 10MG;40MG, TABLET;ORAL - 10MG;80MG

RELATED EXCIPIENT COMPANIES

Suppliers, 36 Kerry, 19 BASF, 18 Roquette, 13 Microlex e.U, 12 Sigachi Industries, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Corel Pharma Chem, 10 Gangwal Healthcare, 8 Gangwal Chemicals, 7 Seppic, 7 DFE Pharma, 6 SPI Pharma, 6 Lonza Capsugel, 5 Pharmatrans-Sanaq, 5 Prachin Chemical, 5 Boai NKY Pharmaceuticals Ltd, 5 Ideal Cures Pvt Ltd, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 Ingredion Pharma Solutions, 4 DKSH, 4 Vasa Pharmachem, 3 Kima Chemical, 2 The Dow Chemical Company, 2 Alcedo Pharmachem, 2 Minakem, 2 Nanjing Well Pharmaceutical, 2 Jai Radhe Sales, 2 Ulanqab Kema New Material, 1 Aeon Procare, 1 Pharm-RX Chemical, 1 NEWEDGE Overseas, 1 Chynops Pharma, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 ACG Worldwide, 1 Qualicaps

EXCIPIENTS BY APPLICATIONS

64 Fillers, Diluents & Binders, 47 Coating Systems & Additives, 43 Disintegrants & Superdisintegrants, 35 Direct Compression, 26 Granulation, 25 Controlled & Modified Release, 22 Lubricants & Glidants, 17 Thickeners and Stabilizers, 12 Co-Processed Excipients, 11 Chewable & Orodispersible Aids, 10 Solubilizers, 9 Film Formers & Plasticizers, 9 Taste Masking, 7 API Stability Enhancers, 5 Empty Capsules, 5 Coloring Agents, 4 Emulsifying Agents, 4 Parenteral, 4 Vegetarian Capsules, 3 Rheology Modifiers, 2 Topical

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 49 Finished Drug Prices

MARKET PLACE

17 APIs, 5 DOSSIERS // FDF

PATENTS

19 US Patents, 3 US Exclusivities, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

6 BioAnalytical Methods, 2 USP, 2 Others

DIGITAL CONTENT

8 Data Compilation & Company Tracker #PharmaFlow, 108 News

Information, Expiry, & Status of FDA Orange Book Exclusivities covering Ezetimibe

Ezetimibe

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

75 Suppliers

30 USDMF

10 JDMF

15 EU WC

61 KDMF

17 NDC API

49 Listed Suppliers

DEVELOPMENTS

16 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

27 Suppliers

DOSSIERs // Finished Dosage Forms

312 Dossiers

62 FDA Orange Book

76 Europe

21 Canada

21 Australia

35 South Africa

97 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 10MG

TABLET;ORAL - 10MG;10MG

TABLET;ORAL - 10MG;20MG

TABLET;ORAL - 10MG;40MG

TABLET;ORAL - 10MG;80MG

RELATED EXCIPIENT COMPANIES

Suppliers

36 Kerry

19 BASF

18 Roquette

13 Microlex e.U

12 Sigachi Industries

11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

10 Corel Pharma Chem

10 Gangwal Healthcare

8 Gangwal Chemicals

7 Seppic

7 DFE Pharma

6 SPI Pharma

6 Lonza Capsugel

5 Pharmatrans-Sanaq

5 Prachin Chemical

5 Boai NKY Pharmaceuticals Ltd

5 Ideal Cures Pvt Ltd

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 Ingredion Pharma Solutions

4 DKSH

4 Vasa Pharmachem

3 Kima Chemical

2 The Dow Chemical Company

2 Alcedo Pharmachem

2 Minakem

2 Nanjing Well Pharmaceutical

2 Jai Radhe Sales

2 Ulanqab Kema New Material

1 Aeon Procare

1 Pharm-RX Chemical

1 NEWEDGE Overseas

1 Chynops Pharma

1 Qianhao Chemical (Hebei) Co., Ltd

1 ACG Worldwide

1 Qualicaps

EXCIPIENTS BY APPLICATIONS

64 Fillers, Diluents & Binders

47 Coating Systems & Additives

TABLET;ORAL - EQ 10MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 20MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 40MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 80MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons